1. Progesterone receptor antagonists are potential inhibitors of breast cancer stem cell activity. (July 2016) Authors: Alferez, D.; Eyre, R.; Spence, K.; Hayhurst, W.; Chresta, C.; Sacha, H.; Clarke, R. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sulforadex targets breast cancer stem-like cells in patient-derived cells and xenograft tumours. (July 2016) Authors: Simões, B.M.; Denis, A.; Eyre, R.; Spence, K.; Santiago-Gómez, A.; Sarmiento-Castro, A.; Tanaka, I.; Howat, D.; Howell, S.; Clarke, R. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The bone metastatic niche promotes breast cancer stem cell activity via IL-1β-Wnt signalling. (July 2016) Authors: Eyre, R.; Spence, K.; Alferez, D.; Santiago-Gomez, A.; Hart, C.; Simoes, B.; Brown, M.; Gurney, A.; Farnie, G.; Clarke, R. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The epidemiology of bone cancer diagnosed in 0–49-year-olds in northern England, 1981–2002. (9th September 2009) Authors: Feltbower, R. G.; Eyre, R.; James, P. W.; Blakey, K.; Mubwandarikwa, E.; Forman, D.; McKinney, P. A.; Pearce, M. S.; McNally, R. J. Q. Journal: Journal of epidemiology and community health Issue: Volume 63(2009)Supplement 2 Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗